Furthermore, since ARMC4 expression is also decreased in several other cancers, including breast and ovarian cancers, our identification and characterization of ARMC4’s function in CRC may serve as the basis for future studies into other hyperactivated NF-κB related cancers or diseases as well. This evidence concerns the gene NFKB1 and colorectal carcinoma.